A Ray of Hope for Those Immobilized by Hospitalization or Injury? Analyzing the Research on the Plant-Derived Supplement "PB125"

A Ray of Hope for Those Immobilized by Hospitalization or Injury? Analyzing the Research on the Plant-Derived Supplement "PB125"

Can Blood Vessels Be Protected During Inactivity? Potential Indicated by U.S. University Supplement Study

Injury prevents walking. Spending time in bed before and after surgery. Even if you know it's better to move your body, there are times when it's difficult for anyone.

At such times, can we increase what we can do to protect the body? The research team from the University of Utah in the U.S. examined the supplement "PB125," which contains plant-derived ingredients.

When reading this study, it is important not to hastily view it as a product that "cancels out lack of exercise." What we want to focus on is how much potential has been revealed as research supporting people who are forced to limit their activities.


Vascular Response Examined in a Trial with 44 Participants

The study involved 20 young adults with an average age of 27 and 24 older adults with an average age of 67. PB125 or a placebo was randomly assigned, and a double-blind method was used where neither the participants nor the evaluators knew the assignments.

Two weeks after starting intake, the older adults underwent five days of bed rest, while the younger adults had their legs immobilized for two weeks, continuing the intake during this period.

The main focus was on indicators of vascular endothelial function, such as the ability of blood vessels to dilate in response to changes in blood flow. In older adults, indicators in the arms and legs improved after PB125 intake and were maintained during the rest period. In younger adults, similar improvements were not observed during normal activity periods, but the potential to suppress functional decline after leg immobilization was indicated.

In other words, the response varies depending on age and activity status. The results do not suggest that vascular function improves uniformly for everyone who takes it.


The Aim is the Body's Defense Mechanism

PB125 is a plant-derived product containing rosemary, ashwagandha, and luteolin. The manufacturer describes it as a product that acts on a mechanism called "Nrf2," which is related to cellular defense.

Though the name is complex, the idea is to "harness the body's inherent defense functions."

However, research results using specific formulations cannot be generalized to the effects of all plant-derived supplements. Even if the same named ingredients are included, differences in product formulation and quantity mean the conditions are not the same as in this trial.

Instead of choosing based solely on words like "natural ingredients" or "antioxidant," it's necessary to look at what was tested, on whom, and under what conditions.


Improvement in Vascular Indicators and Disease Prevention are Separate Questions

The results are promising, but the trial involved a small number of participants over a short period. While there were changes in vascular test values, it cannot be concluded that myocardial infarction or stroke will be reduced.

Similarly, lifestyle effects such as recovery of walking ability, earlier discharge, or reducing the number of people needing care need to be verified separately.

There is a distance that is easy to overlook when reading health news. Between the discovery that "desirable changes occurred in the body" and the demonstration that "the individual's life improves," there are still stages that need verification.

Future research will need to confirm the sustainability of effects, safety, and usefulness in actual recuperation life with more participants.


On Social Media, Welcomed by the Manufacturer, General Reactions Still Uncertain

On social media, Pathways Bioscience, the manufacturer, introduced the research results on LinkedIn. The post conveyed the expectation that favorable effects on vascular function were demonstrated in a double-blind, placebo-controlled human trial.

However, this is the evaluation of the company selling the product, not the impressions of independent users.

Within the scope of publicly available information confirmed this time, it was not possible to sufficiently gather general user reactions to this study. Trends in public opinion, such as "praised on social media" or "voices of doubt are emerging," cannot be determined.

In the topic of supplements, research introductions, product promotions, and personal experiences are lined up on the same screen. When reading posts, attention should be paid not only to the content but also to who is sending it.


For Japanese Readers, Consider Separating "Those Who Can Move" and "Those Who Cannot"

For those who continue desk work, the story of "protecting blood vessels during inactivity" might seem appealing. However, this trial did not investigate whether daily sitting can be offset by supplements.

The Ministry of Health, Labour and Welfare's "2023 Physical Activity and Exercise Guide for Health" recommends moving the body even a little more than now, according to individual conditions. It also introduces the idea of interrupting prolonged sitting, for example, every 30 minutes.

For those who can move, creating opportunities to be active in daily life, such as standing during work breaks or increasing short movements, becomes fundamental.

On the other hand, those instructed to rest due to hospitalization or injury have different circumstances. It is necessary to consult with the responsible medical personnel without changing exercise amounts or supplement use based on self-judgment.

The question posed by this study is what additional support can be provided in the future for such people. Can the burden on the body during the necessary rest for recuperation be reduced even slightly? The research on PB125 should be seen as a step in verifying that possibility.


Sources

  1. The Daily Utah Chronicle:
    https://dailyutahchronicle.com/2026/11/16/u-clinical-trial-finds-supplement-may-help-protect-blood-vessel-function-during-inactivity/

  2. Free Radical Biology and Medicine: Original Research Paper
    Participants, trial methods, and vascular function evaluation results. The paper is titled "Targeted Nrf2 activation improves vascular endothelial function with aging and prevents vascular dysfunction following disuse in younger and older adults."
    https://pubmed.ncbi.nlm.nih.gov/42105792/pubmed.ncbi.nlm.nih.gov

  3. Pathways Bioscience: PB125 Product and Formulation Description
    Explanation from the manufacturer about the ingredients and their action on Nrf2. Referenced separately from independent effect assessments.
    https://pathwaysbio.com/Pathways Bioscience

  4. Official LinkedIn of Pathways Bioscience: Reactions to the Research
    Official company communication welcoming the results of clinical trials on vascular function. Not indicative of general user evaluations.
    https://pa.linkedin.com/company/pathways-bioscience-llcLinkedIn

  5. Ministry of Health, Labour and Welfare: 2023 Physical Activity and Exercise Guide for Adults
    About increasing physical activity, reducing prolonged sitting, and the idea of interrupting sedentary behavior.
    https://kennet.mhlw.go.jp/information/information/exercise/s-00-002.htmlHealth Japan 21 Action Support System Website